Moreover, we observed a significant positive correlation between ISCU and immune checkpoint inhibitor-regulating genes (PD1, PDL1, CTLA4, etc.)among the core genes, which prompted us to investigate its role and potential mechanisms in cervical cancer immune therapy and regulation of the immune microenvironment. The gene discussed is CTLA4; the disease is cervical cancer.